ASX/BDX (ASX/BDX)

Australian Securities Exchange: ASX/BDX · AUD

A$0.08

+0.00 (0.0%)· Recorded snapshot

Market cap	29.5M
Revenue (ttm)	2.4M
Net income (ttm)	-7.4M
EPS (ttm)	-A$0.02
Shares out	368.7M
Volume	3,353
Beta	0.74

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.4M
Net income (ttm): -7.4M
EPS (ttm): -A$0.02
Market cap: 29.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-273.3

P25 n/aP50 n/aP75 n/a

ROIC-60.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/BDX indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

AUD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-17
Enterprise value	AUD 34.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2010
Industry	Diagnostics & Research
Is primary listing	Yes
ISIN number	AU0000160921
Last earnings date	2026-09-03
Last refreshed	2026-10-29
Market cap	AUD 29.5M
Next earnings date	2026-11-17
Price	AUD 0.08
Price currency	AUD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	asx/BDX
Website	https://www.bcaldiagnostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-25.07%
EV/Sales	14.8x
FCF / EV yield	-19.01%
FCF yield	-22.44%
Industry forward P/E	17.02x
Industry P/E	62.46x
P/S ratio	12.54x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA margin	-280.16%
Gross margin	100%
Operating margin	-300.54%
Pretax margin	-313.39%
ROA	-50.29%
ROA (5Y)	-36.94%
ROCE	-151.72%
ROE	-273.29%
ROE (5Y)	-116.62%
ROIC	-60.16%
SBC / revenue	13.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-11.25%
Gross profit growth (Q)	-14.67%
Gross profit growth 3Y	-5.54%
Gross profit growth 5Y	53.59%
Net income growth years	0
Revenue growth	-11.25%
Revenue growth (Q)	-14.67%
Revenue growth (QoQ)	-15.17%
Revenue growth 3Y	-5.54%
Revenue growth 5Y	53.59%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -458,986
Depreciation and amortization	AUD 479,294
EBIT	AUD -7.1M
EBITDA	AUD -6.6M
EPS	AUD -0.02
FCF per share	AUD -0.02
Financing cash flow	AUD 4.7M
Free cash flow	AUD -6.6M
Free cash flow minus SBC	AUD -6.9M
Gross profit	AUD 2.4M
Investing cash flow	AUD -1.4M
Net borrowing	AUD 4.7M
Net cash flow	AUD -2.9M
Net income	AUD -7.4M
Operating cash flow minus SBC	AUD -6.5M
Operating income	AUD -7.1M
Revenue	AUD 2.4M
Stock-based compensation	AUD 324,417

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.77
Book value per share	AUD -0.00
Interest coverage	-20.39
Long-term assets	AUD 3.6M
Long-term liabilities	AUD 5.5M
Net cash (debt)	AUD -5.3M
Net cash / market cap	-18.07%
Piotroski F-Score	2
Property, plant and equipment	AUD 2M
Shareholders' equity	AUD -826,193
Tangible book value	AUD -826,193
Tangible book value per share	AUD -0.00
Total assets	AUD 7.7M
Total cash	AUD 1.6M
Total debt	AUD 6.9M
Total liabilities	AUD 8.5M
WACC	7.49%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.27
Current assets	AUD 4.1M
Current liabilities	AUD 3M
Current ratio	1.36
Net working capital	AUD 1.3M
Quick ratio	1.32
Working capital	AUD 1.1M
Working capital turnover	0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.22%
Shareholder yield	-2.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.08
1D price change	0%
1M price change	-1.23%
1M total return	-1.23%
1W price change	2.56%
1W total return	2.56%
1Y price change	-4.76%
1Y return CAGR	-4.77%
1Y total return	-4.76%
20-day SMA	AUD 0.08
200-day SMA	AUD 0.09
3M price change	12.68%
3M total return	12.68%
3Y price change	-23.81%
3Y return CAGR	-8.66%
3Y total return	-23.81%
50-day SMA	AUD 0.07
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.16
52-week high date	2026-01-12
52-week low	AUD 0.05
52-week low date	2026-08-24
5Y price change	-50%
5Y return CAGR	-12.95%
5Y total return	-50%
All-time high	AUD 0.28
All-time high date	2021-07-21
All-time low	AUD 0.05
All-time low date	2023-03-13
Average true range (ATR)	AUD 0.00
Average volume	165.5K
Beta (1Y)	-0.72
Beta (2Y)	-0.06
Beta (5Y)	0.74
Change from 52-week high	-48.39%
Change from 52-week low	53.85%
Change from all-time high	-70.91%
Change from all-time low	56.86%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 268
High price	AUD 0.08
Low price	AUD 0.08
Monthly RSI	46.27
Open price	AUD 0.08
Previous close	AUD 0.08
Price vs 150-day SMA	0.5%
Price vs 20-day SMA	-5.77%
Price vs 200-day SMA	-9.91%
Price vs 50-day SMA	7.53%
Relative volume	0.02
RSI	48.83
Sharpe ratio	0.55
Sharpe ratio (3Y)	0.46
Sortino ratio	1.07
Sortino ratio (3Y)	0.85
Volume	3.4K
Weekly RSI	50.04
YTD price change	-23.81%
YTD total return	-23.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	175.3M
Shares change (QoQ)	0.79%
Shares change (YoY)	2.22%
Shares held by insiders	28.98%
Shares held by institutions	6.35%
Shares outstanding	368.7M

Deeper analysis on ASX/BDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/BDX report

Is a complete ASX/BDX research report available?

No complete published report is available for asx/BDX (ASX/BDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/BDX (ASX/BDX)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/BDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/BDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/BDX

Frequently asked questions